Carbonyl reductase and NADPH cytochrome P450 reductase activities in human tumoral versus normal tissues
López de Cerain A, Marín A, Idoate MA, Tuñón MT, Bello J.
Toxicology Department, Universidad de Navarra, Pamplona, Spain.
Magazine: European Journal of Cancer
Date: Feb 1, 1999Breast Cancer Area Pathological Anatomy [SP]
The use of bioreductive agents in enzyme-directed bioreductive therapy has been proposed to take advantage not only of hypoxia in tumours, but also of the presence of reductases that metabolise such compounds. In this study, we studied the activities of NADPH cytochrome P450 reductase (P450R) and carbonyl reductase (CR) in 17 human lung tumours and 18 human breast tumours, together with the corresponding normal tissues.
For lung cancer but not for breast cancer there was a significant difference in the CR activity between normal and tumour tissue. CR activity was increased with respect to the normal tissue between 2-fold and 40-fold indicating heterogeneity in tumour samples. No relationship was found between CR activity and the histological type, tumoral grade or TNM stage of the tumours.
Although some variation in P450R activity in tumoral versus normal tissues was found in the majority of the samples studied, no significant differences could be demonstrated.
CITATION Eur J Cancer. 1999 Feb;35(2):320-4
you mayBE INTERESTED
The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.
The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.
Learn why we are different from other healthcare centers. Quality, speed, comfort and results.